Informes de Expertos (IDE) latest report, titled “
Mercado Latinoamericano de los Medicamentos Oncológicos Genéricos,Informey Pronóstico 2021-2026”, anticipates that the Latin America generic oncology drugsmarket size will reach USD XX Billion by 2026, owing topatent expiries of blockbuster drugs andgrowing number of cancer patients. Factors that increases the risk of cancer include increased exposure to Ultraviolet Rays, food adulteration, traces of pesticides in the body, smoking, lifestyle factors, etc. High costs associated with cancer treatment leading to increasing government emphasis on generic cancer drugs, and the constant R&D activities to bring new and innovative drugs in the market represent some of the significant growth-inducing factors.
